Telemus Capital’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-2,892
Closed -$266K 436
2020
Q2
$266K Sell
2,892
-300
-9% -$24K 0.02% 357
2020
Q1
$274K Buy
3,192
+212
+7% +$17.2K 0.02% 320
2019
Q4
$276K Buy
+2,980
New +$262K 0.02% 324

Other funds holding EXAS

Telemus Capital's EXAS Position: Q3 2020 in Review

Telemus Capital sold out of Exact Sciences (EXAS) in Q3 2020, closing a stake of 2,892 shares — an estimated $266K sold.

Telemus Capital first reported a position in EXAS in Q4 2019 and held it in 3 quarters. The position peaked at $276K in Q4 2019. 516 funds tracked by Wall St. Rank hold EXAS as of Q3 2020.

  • Telemus Capital reported no remaining Exact Sciences position as of Q3 2020 after selling out during the quarter.
  • Telemus Capital sold 2,892 Exact Sciences shares in Q3 2020, an estimated $266K.
  • Telemus Capital first reported a position in Exact Sciences in Q4 2019 and held it in 3 quarters.
  • Telemus Capital's Exact Sciences position peaked at $276K in Q4 2019.
  • 516 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2020.

Based on Telemus Capital's 13F filing for Q3 2020, filed 2 Nov 2020.